CBMT-16. EGFRvIII EXPRESSION CONFERS CHEMOSENSITIVITY BY INCREASING DNA MISMATCH REPAIR PROTEIN EXPRESSION AND REPLICATION STRESS

MGMT promoter methylation is the only accepted biomarker with prognostic role in GBM but its routine implementation is limited partly response to TMZ is heterogeneous, but also due to lack of effective alternative treatment options. Therefore, additional biomarkers are needed to enable better predic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Struve, Nina, Binder, Zev A, Stead, Lucy F, Brend, Tim, Bagley, Stephen J, Faulkner, Claire, Ott, Leonie, Müller-Goebel, Justus, Weik, Anna-Sophie, Hoffer, Konstantin, Rieckmann, Thorsten, Christin Parplys, Ann, Burmester, Jasmin, Henze, Marvin, Morrissette, Jennifer J D, Schüller, Ulrich, Petersen, Cordula, Rothkamm, Kai, Kurian, Kathreena M, Short, Susan C, Kriegs, Malte
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Cell Biology and Metabolism
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847190/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.138
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados